Interphase cytogenetic analysis oferbB2 and topollα co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinomain situ
Autor: | W N Keith, W. D. George, D. S. Murphy, J Coutts, Stan B. Kaye, Robert S. Brown, Elizabeth Mallon, McHardy P |
---|---|
Rok vydání: | 1995 |
Předmět: |
Cancer Research
medicine.medical_specialty Pathology Receptor ErbB-2 Breast Neoplasms Chromosome Disorders Biology Breast cancer medicine Humans skin and connective tissue diseases In Situ Hybridization Fluorescence Chromosome Aberrations Polysomy Carcinoma in situ Carcinoma Ductal Breast Gene Amplification Cytogenetics Genes erbB-2 Ductal carcinoma Aneuploidy medicine.disease Chromosome 17 (human) DNA Topoisomerases Type II Oncology Tumor progression Cancer research Breast carcinoma Carcinoma in Situ Chromosomes Human Pair 17 |
Zdroj: | International Journal of Cancer. 64:18-26 |
ISSN: | 1097-0215 0020-7136 |
Popis: | Breast cancer is a genetically complex disease. Fluorescence in situ hybridisation can be used to analyse the genetics of breast-cancer progression by interphase cytogenetics. We have analysed the histological distribution of erbB2 and topollα co-amplification in paraffin sections of invasive breast cancer and show that the co-amplified loci share the same histological distribution in the tumour and have a similar nuclear distribution within individual nuclei. Regions of the tumours without amplification are easily recognized and tumours with erbB2 and topollα co-amplification can be distinguished from those with erbB2 amplification alone. In addition, FISH was used to show polysomy of chromosome 17 in non-invasive ductal carcinoma in situ of the breast and erbB2 amplification in both the invasive and non-invasive components of a breast cancer biopsy. This report of an interphase cytogenetic analysis of non-invasive breast carcinoma in situ demonstrates the usefulness of FISH for the genetic study of breast cancer progression. © 1995 Wiley-Liss, Inc. |
Databáze: | OpenAIRE |
Externí odkaz: |